Search Tag: Pancreatic Stone Protein (PSP) biomarker

ICU Management

Fapon-lascco-abionic-formed-strategic-collaboration-for-psp-sepsis-diagnosis-in-china

2023 26 Oct

Fapon, a leading life sciences company, entered into a strategic cooperation agreement with two Swiss biotech companies LASCCO SA and Abionic SA, that granted Fapon an exclusive license to utilize the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. This strategic partnership will enable Fapon to engage in the research, development,...Read more